Stone Pharmaceutical: Enters into Exclusive Licensing Agreement with Madrigal for SYH2086, Reserving Right to Receive Up to $207.5 Million Total Payment
Global Times July 30th ｜ Stone Pharmaceutical (01093.HK) announced that the company has entered into an exclusive licensing agreement with Madrigal Pharmaceuticals, Inc. for the global developmen